Robert Michael Dudley, Chief Executive Officer at Transcode Therapeutics, Inc. (RNAZ), bought 38,000 shares at $2.76 ($105K) on 2023-06-09, disclosed to the SEC on 2023-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 19,000 | $52K | 50.0% |
| 2 | $2.76 | 19,000 | $52K | 50.0% |
| Total | $2.76 avg | 38,000 | $105K | 100% |
| Filing → |
| RNAZ | BUY | 2022-09-16 | $23K | — | Filing → |
| RNAZ | BUY | 2022-06-01 | $55K | — | Filing → |